Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

An FDA approved device to test the health of a patient's blood vessels, which involves putting an oxygen probe on the participant's finger.

A device used to conduct blood pressure monitoring using a home blood pressure cuff that participant wears for 24 hours.

A test used to conduct an ultrasound of participant's heart.

A survey that will be given to participants to report their quality of life and symptoms related to multiple myeloma.

Routinely collected for all participants who begin carfilzomib treatment.